Vitura Health Limited (ASX:VIT)
0.0690
+0.0010 (1.47%)
Apr 24, 2025, 1:31 PM AEST
Vitura Health Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
Cash & Equivalents | 7.4 | 11.35 | 18.85 | 16.08 | 2.08 | 14.69 | Upgrade
|
Cash & Short-Term Investments | 7.4 | 11.35 | 18.85 | 16.08 | 2.08 | 14.69 | Upgrade
|
Cash Growth | -43.08% | -39.80% | 17.24% | 673.19% | -85.84% | 9097.17% | Upgrade
|
Accounts Receivable | 8.1 | 11.9 | 9.27 | 5.74 | 1.98 | 0.01 | Upgrade
|
Other Receivables | 0.74 | 1.84 | 0.07 | 0.02 | 0.2 | 0.02 | Upgrade
|
Receivables | 8.84 | 13.74 | 9.34 | 5.76 | 2.18 | 0.03 | Upgrade
|
Inventory | 7.09 | 5.01 | 6.91 | 5.03 | 3.1 | 0.19 | Upgrade
|
Prepaid Expenses | 0.45 | 0.79 | 0.73 | 0.68 | 0.16 | 0.18 | Upgrade
|
Other Current Assets | 0.09 | 0.09 | 0.19 | 0.04 | - | 0.16 | Upgrade
|
Total Current Assets | 25.99 | 30.97 | 36 | 27.59 | 7.52 | 15.25 | Upgrade
|
Property, Plant & Equipment | 5.9 | 6.47 | 2.41 | 5.58 | 0.91 | 0.49 | Upgrade
|
Goodwill | 18.52 | 18.52 | 6.83 | 6.83 | - | 0.29 | Upgrade
|
Other Intangible Assets | 13.63 | 12.72 | 0.27 | 0.33 | 0.16 | 0.2 | Upgrade
|
Long-Term Deferred Tax Assets | 1.39 | 1.83 | 1 | 1.94 | 0.08 | - | Upgrade
|
Other Long-Term Assets | 1.53 | 0.77 | 0.37 | 0.6 | 0.14 | - | Upgrade
|
Total Assets | 70.79 | 71.28 | 46.9 | 42.87 | 8.8 | 16.23 | Upgrade
|
Accounts Payable | 9.51 | 11.03 | 6.92 | 7.59 | 3.16 | 0.1 | Upgrade
|
Accrued Expenses | 2.65 | 3.77 | 2.87 | 1.84 | 0.41 | 0.38 | Upgrade
|
Current Portion of Long-Term Debt | 4.5 | 1.2 | - | - | - | - | Upgrade
|
Current Portion of Leases | 0.46 | 0.53 | 0.24 | 0.49 | 0.18 | 0.1 | Upgrade
|
Current Income Taxes Payable | - | - | 0.24 | 1.66 | 0.54 | - | Upgrade
|
Current Unearned Revenue | 0.02 | 0.01 | - | - | - | - | Upgrade
|
Other Current Liabilities | 0.02 | 6.83 | 0.6 | 0.59 | - | 0.04 | Upgrade
|
Total Current Liabilities | 17.17 | 23.36 | 10.87 | 12.17 | 4.29 | 0.63 | Upgrade
|
Long-Term Debt | 8.01 | 4.12 | - | - | - | 1.79 | Upgrade
|
Long-Term Leases | 4.96 | 5.18 | 1.04 | 4.57 | 0.54 | 0.32 | Upgrade
|
Total Liabilities | 30.29 | 32.84 | 11.99 | 16.79 | 4.84 | 2.73 | Upgrade
|
Common Stock | 31.28 | 30.79 | 24.04 | 22.78 | 3.68 | 20.01 | Upgrade
|
Retained Earnings | 14.38 | 12.67 | 14.74 | 6.47 | 0.43 | -6.78 | Upgrade
|
Comprehensive Income & Other | -4.7 | -4.68 | -3.8 | -3.15 | -0.14 | 0.21 | Upgrade
|
Total Common Equity | 40.96 | 38.78 | 34.98 | 26.1 | 3.96 | 13.44 | Upgrade
|
Minority Interest | -0.46 | -0.34 | -0.08 | -0.03 | - | 0.05 | Upgrade
|
Shareholders' Equity | 40.5 | 38.44 | 34.9 | 26.07 | 3.96 | 13.5 | Upgrade
|
Total Liabilities & Equity | 70.79 | 71.28 | 46.9 | 42.87 | 8.8 | 16.23 | Upgrade
|
Total Debt | 17.94 | 11.02 | 1.28 | 5.06 | 0.72 | 2.21 | Upgrade
|
Net Cash (Debt) | -10.54 | 0.33 | 17.57 | 11.02 | 1.36 | 12.48 | Upgrade
|
Net Cash Growth | - | -98.14% | 59.48% | 709.34% | -89.09% | - | Upgrade
|
Net Cash Per Share | -0.02 | 0.00 | 0.03 | 0.02 | 0.00 | 0.14 | Upgrade
|
Filing Date Shares Outstanding | 581.65 | 575.87 | 556.53 | 550.63 | 128.75 | 128.75 | Upgrade
|
Total Common Shares Outstanding | 581.65 | 575.87 | 556.53 | 550.63 | 128.75 | 128.75 | Upgrade
|
Working Capital | 8.82 | 7.61 | 25.14 | 15.42 | 3.23 | 14.62 | Upgrade
|
Book Value Per Share | 0.07 | 0.07 | 0.06 | 0.05 | 0.03 | 0.10 | Upgrade
|
Tangible Book Value | 8.81 | 7.55 | 27.88 | 18.94 | 3.81 | 12.95 | Upgrade
|
Tangible Book Value Per Share | 0.02 | 0.01 | 0.05 | 0.03 | 0.03 | 0.10 | Upgrade
|
Machinery | 0.97 | 0.95 | 0.76 | 0.52 | 0.2 | 0.13 | Upgrade
|
Construction In Progress | 0.02 | 0.06 | 0.04 | 0.05 | - | - | Upgrade
|
Leasehold Improvements | 1.19 | 1.19 | 1.09 | 0.43 | 0.12 | 0.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.